Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older
A Pfizer-sponsored study is evaluating how well Prevnar 20 works to prevent pneumonia in adults aged 65 and older; the trial is currently ac…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating anti-thrombotic therapy to reduce complications in community-acquired pneumonia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia [Phase 4]
This is a Phase 4 trial evaluating ceftriaxone dosage for non-critical community-acquired pneumonia. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
This clinical trial update describes a study evaluating antibiotic stewardship strategies in primary and urgent care settings to reduce anti…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management
A completed clinical trial evaluating the susceptibility of amoxicillin/clavulanic acid in adults with severe community-acquired pneumonia r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward [Phase 3]
A Phase 3 trial is comparing amoxicillin alone to amoxicillin/clavulanate for treating community-acquired pneumonia in patients aged 65 and …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) [Phase 3]
Phase 3 trial evaluating Trimodulin (BT588) for severe community-acquired pneumonia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) [Phase 2]
Phase 2 trial evaluating nogapendekin alfa-inbakicept in combination with iNKT cell therapy for critically ill adults with severe community-…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia [Phase 3]
Phase 3 trial evaluating Nogapendekin alfa inbakicept with iNKT cell therapy for critically ill adults with severe community-acquired pneumo…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. [Phase 2]
Phase 2 clinical trial results evaluating the safety and efficacy of AON-D21 in adults with severe community-acquired pneumonia.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Urinary Antigen Test for Stretococcus Pneumoniae Serotype Prevalence in Community Acquired Pneumonia
Clinical trial evaluating a urinary antigen test for Streptococcus pneumoniae serotype prevalence in community-acquired pneumonia; sponsored…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP) [Phase 4]
A Phase 4 clinical trial is testing whether hydrocortisone or prednisolone provides different outcomes in adults with community acquired pne…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of tNGS on CAP Patients With Initial Treatment Failure [NA]
A clinical trial update evaluating the effect of targeted next-generation sequencing (tNGS) in community-acquired pneumonia (CAP) patients w…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia [NA]
A clinical trial update exploring strategies to reduce antimicrobial overuse in community-acquired pneumonia through targeted therapy and an…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP [Phase 4]
Phase 4 clinical trial evaluating whether a shorter antibiotic course is as effective as standard duration for children hospitalized with co…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Frailty and Outcomes in Older Emergency Department Patients With Pneumonia
This clinical trial update examines the impact of frailty on outcomes among older emergency department patients with community-acquired pneu…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin [NA]
Completed clinical trial evaluating swab testing to optimize empiric vancomycin use in community-acquired pneumonia; results have been poste…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
Ain Shams University is conducting a clinical trial to evaluate whether plasma D-dimer levels predict the severity of inflammatory response …
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
A completed study deriving and validating a risk score for pneumonia involving resistant organisms. The trial assessed the RESPIRE risk eval…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms [NA]
This clinical trial update describes a study aiming to promote optimal treatment for community-acquired pneumonia in emergency rooms, sponso…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Lower Respiratory Tract Infections Managed in Primary Care in France
A completed French clinical trial evaluated how lower respiratory tract infections, including community-acquired pneumonia and COPD exacerba…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
A recruiting clinical trial sponsored by the Hellenic Institute for the Study of Sepsis is studying cardiovascular disease progression in su…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia [Phase 2]
Phase 2 blinded efficacy and safety study of CAL02 in addition to standard of care for severe community-acquired bacterial pneumonia; the tr…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: HVNI vs CPAP in Children With Acute Respiratory Distress [NA]
A completed clinical trial evaluating high-velocity nasal insufflation (HVNI) versus CPAP in children with acute respiratory distress due to…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP) [NA]
A clinical trial evaluating different outpatient antibiotic strategies for children with community-acquired pneumonia to determine optimal t…